What is the Breast Cancer Index Test?
This post is sponsored by Biotheranostics, Inc. (Breast Cancer Index®). Thoughts and opinions are my own.
When I turned 40, my doctor said, “It’s time for your first mammogram.” It seemed surreal to think that I had hit “that age” where annual mammograms would become a part of my new health regimen. And the fact that I was 40. How was THAT possible, as well?
So, I scheduled my first mammogram.
The exam was a little bit uncomfortable, but not painful. Since it was my first mammogram, I had many images taken to create a “baseline” for my breasts. All seemed to go well and I returned home.
A few days later, I received a call from the doctor that there were some spots that need further examination via an ultrasound. I was told that I had “dense breasts” and that is common and normal, but it didn’t exactly ease my fear of hearing that.
I would end up doing an ultrasound twice before I received the “all clear” note in the mail. It was excruciating waiting for that letter.
What I learned about my first mammogram experience is the importance of staying on top of my breast health. It is my responsibility as a woman and breast cancer is not an illness that just affects a certain class, age, or DNA of a female. Breast cancer knows no boundaries.
I know very little about my family’s history with breast cancer, sans a great aunt that did battle with it. The details are not known, as well as if breast cancer runs in my family, so it is up to me to be proactive and responsible for my own health. I also feel a responsibility to encourage my female friends and loved ones to be proactive as well. I have seen the toll breast cancer has taken on friends of mine over the years, at various ages, and I don’t want another minute to go by that women are not educated about all that breast health entails.
Not. Another. Minute.
Did you know that nearly 95% of women with early-stage, hormone receptor-positive (HR+) breast cancer do not benefit from anti-estrogen therapy beyond 5 years? I didn’t either.
I recently partnered with the maker of Breast Cancer Index, who informed me that since approximately 3-5% of women do benefit from anti-estrogen therapy after 5 years, the Breast Cancer Index test could give women a reason to continue their therapy for 10 years to keep the cancer from coming back. And for the women who do not benefit after 5 years, they will be able to have some peace of mind about discontinuing treatment.
What is the Breast Cancer Index Test?
Breast Cancer Index (BCI) is a test that provides information to help women diagnosed with early-stage, hormone receptor-positive (HR+) breast cancer, and their oncologists make personalized decisions about extending anti-estrogen (also called hormonal or endocrine) therapy beyond 5 years. (Read Intended Use and limitations at breastcancerindex.com)
Breast Cancer Index is a test that looks at your initial tumor sample to provide two pieces of information:
- Whether an additional 5 years of anti-estrogen therapy is likely to help reduce your risk of the cancer returning (recurrence) as metastatic disease
- Your individual risk of metastatic recurrence between 5 and 10 years after your initial diagnosis, which is presented as a percentage risk [e.g., 3.2% or 7.5%]
Over the next few months, I will be sharing more about Breast Cancer Index with you. I’m excited to preach what I learn from the rooftops to support my fellow females, both those who have been affected by breast cancer and those who haven’t. Both are equally important to inform and keep accountable.
In the meantime, learn more about Breast Cancer Index by visiting breastcancerindex.com and follow #notanotherminute on social media.